Nuveen
AGTC

Nuveen’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Nuveen’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-867,592
Closed -$4.4M – 3603
2021
Q1 		$4.4M Buy
867,592
+762,841
+728% +$3.96M ﹤0.01% 2225
2020
Q4 		$428K Buy
104,751
+3,900
+4% +$19.2K ﹤0.01% 3076
2020
Q3 		$490K Sell
100,851
-10
-0% -$55 ﹤0.01% 2963
2020
Q2 		$559K Buy
+100,861
New +$462K ﹤0.01% 2855
2015
Q3 		– Sell
-26,044
Closed -$400K – 1631
2015
Q2 		$400K Buy
26,044
+181
+0.7% +$3.47K ﹤0.01% 1416
2015
Q1 		$517K Buy
+25,863
New +$578K ﹤0.01% 1353

Other funds holding AGTC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Nuveen's AGTC Position: Q2 2021 in Review

Nuveen sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 867,592 shares — an estimated $4.4M sold.

Nuveen first reported a position in AGTC in Q1 2015 and held it in 6 quarters. The position peaked at $4.4M in Q1 2021. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • Nuveen reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 867,592 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $4.4M.
  • Nuveen first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 6 quarters.
  • Nuveen's Applied Genetic Technologies Corporation position peaked at $4.4M in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.